Question 1

Who should run this audit?

Accepted Answer

Acute medical, general medical, renal, care of the elderly and surgical teams, IMTs, registrars, QI fellows, pharmacists, nurses, AKI leads and governance leads are all well placed. Include a project lead, consultant supervisor, renal, pharmacy and nursing leads where possible.

Question 2

What permissions do I need?

Accepted Answer

Most trusts treat this as clinical audit / service evaluation and do not require ethics approval, but you must register the project with your local clinical audit or governance team before starting. Use only pseudonymised identifiers — do not enter NHS numbers, hospital numbers, names or dates of birth.

Question 3

How do I sample?

Accepted Answer

Use consecutive adult (≥ 16y) admissions with suspected or confirmed AKI over a defined period. A sample of 30–50 per ward gives a reasonable point estimate; 60–100 across the trust supports comparative analysis, stage-level breakdowns and ward-level comparison.

Question 4

What does the tool measure?

Accepted Answer

Whether AKI is recognised and documented, whether clinical and senior review occurred within the locally agreed timeframe, whether volume status, urine output, urinalysis and obstruction were considered, whether medication review and hyperkalaemia management were performed, whether renal referral and critical care escalation happened where required, and whether a post-discharge follow-up plan was documented.

Question 5

What happens after data collection?

Accepted Answer

The dashboard updates in real time. Use the Findings tab to interpret results, the Improvement tab to plan actions and PDSA cycles, and the Export centre to generate editable Word, PowerPoint, A0 poster, Excel and ARCP evidence outputs.

Question 6

Do I need to sign in to see the tool?

Accepted Answer

No. Authentication is handled at the main Lazomis QI website. Inside the tool you will already be in your authenticated workspace, or in demo mode with clearly labelled sample data.